РЕПРОДУКТИВНЫЕ НАРУШЕНИЯ И ИХ ПАТОГЕНЕТИЧЕСКИЕ МЕХАНИЗМЫ У ВИЧИНФИЦИРОВАННЫХ ЖЕНЩИН

Статья; ОбзорВИЧ ИНФ ИММУНОСУПР. 2019; Т. 11, № 4: 20–29. DOI:10.22328/2077-9828-2019-11-4-20-29

Лещенко О.Я.^[1]

Генич Е.В.^[1]

^[1]НЦ проблем здоровья семьи и репродукции

ВИЧ-инфекция

репродуктивное здоровье

гормоны

бесплодие

менструация

половое поведение

Бесплодие

Гормоны

Менструация

Половое поведение

Федеральный Центр СПИД, Официальная статистика по ВИЧ в России (обновляемая, аналитика, графики). https://spid-vichzppp.ru/statistika/epidemiya-vich-spida-v-rossii-2017.html. [Federal AIDS Center, Official statistics on HIV in Russia (updated, Analytics, graphs) (In Russ.)].https://spid-vichzppp.ru/statistika/epidemiya-vich-spida-v-rossii-2017.html

Беляков Н.А., Виноградова Т.Н. Половой путь передачи ВИЧ в развитии эпидемии // ВИЧ-инфекция и иммуносупрессии. 2011. № 3 (4). С. 7–19.

National Association of People Living With HIV/AIDS 2008. AIDS 2008: The Swiss Statement — the debate continues, 2009. Available at http://napwa.org.au/pl/2008/09/aids-2008-the-swiss-statement-the-debate-continues.http://napwa.org.au/pl/2008/09/aids-2008-the-swiss-statement-the-debate-continues

Ogarkov O.B., Ebers A., Zhdanova S. Administrative interventions associated with increased initiation on antiretroviral therapy in Irkutsk // Siberia Public Health Action. 2016. No. 6 (4). Р. 252–254. DOI: 10.5588/pha.16.0050..
DOI: 10.5588/pha.16.0050

Kuete M., Yuan Hong Fang, Tchoua Kemayou A.L., Songo E.A., Yang F., Ma Xiu Lan, Xiong Cheng Liang, Zhang Hui Ping. Scale up use of family planning services to prevent maternal transmission of HIV among discordant couples: a cross-sectional study within a resource-limited setting // Patient Prefer Adherence. 2016. No. 10. Р. 1967–1977. DOI: 10.2147/PPA.S105624..
DOI: 10.2147/PPA.S105624

Leshchenko O., Genich E. Sex behavior and reproductive attitudes of HIV-positive men and women // Maturitas. 2019. No. 124. Р. 152–153. DOI: https://doi.org/10.1016/j.maturitas.2019.04.121..
DOI: 10.1016/j.maturitas.2019.04.121

Kushnir V., Lewis W. Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals // Fertil Steril. 2011. No. 96 (3). Р. 546–553. DOI: 10.1016/j.fertnstert.2011.05.094..
DOI: 10.1016/j.fertnstert.2011.05.094

Heysell S.K., Ogarkov O.B., Zhdanova S. Undertreated hiv and drug-resistant tuberculosis at a referral hospital in Irkutsk // Siberia International Journal of Tuberculosis and Lung Disease. 2016. No. 20 (2). Р. 187–192. DOI: 10.5588/ijtld.14.0961..
DOI: 10.5588/ijtld.14.0961

Nguyen R.H., Gange S.J. Reduced fertility among HIV-infected women associated with viral load in Rakai district, Uganda // Int. J. STD AIDS. 2006. No. 17 (12). Р. 842–846. DOI: 10.1258/095646206779307586..
DOI: 10.1258/095646206779307586

Zaid D., Greenman Y. Human Immunodeficiency Virus Infection and the Endocrine System // Endocrinol. Metab. (Seoul). 2019. Jun; No. 34 (2). Р. 95–105. DOI: 10.3803/EnM.2019.34.2.95..
DOI: 10.3803/EnM.2019.34.2.95

Yalamanchi S., Dobs A., Greenblatt R.M. Gonadal function and reproductive health in women with HIV infection // Endocrinol. Metab. Clin. North Am. 2014. Sep; No. 43 (3). Р. 731–741. DOI: 10.1016/j.ecl.2014.05.00212..
DOI: 10.1016/j.ecl.2014.05.00212

Kolesnikova L.I., Kolesnikov S.I., Darenskaya M.A., Grebenkina L.A., Timofeeva E.V., Leshchenko O.Ya. Evaluation of the pro- and antioxidant status of women with HIV or coinfection // Terapevticheskii arkhiv. 2016. No. 88 (11). Р. 17–21. DOI: 10.17116/terarkh2016881117-21..
DOI: 10.17116/terarkh2016881117-21

Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: Update 2018. Davies N.E.C.G., Ashford G., Bekker L. G., Chandiwana N., Cooper D., Dyer S.J., Jankelowitz L., Mhlongo O., Mnyani C.N., Mulaudzi M.B., Moorhouse M., Myer L., Patel M., Pleaner M., Ramos T., Rees H., Schwartz S., Smit J., van Zyl D.S. // South Afr J HIV Med. 2018. No. 19 (1). Р. 915. Published online 2018 Oct 18. DOI: 10.4102/sajhivmed.v19i1.915..
DOI: 10.4102/sajhivmed.v19i1.915

Harlow S.C., Schuman P.M. Effect of HIV infection on menstrual cycle length // AIDS. 2000. No. 24 (1). Р. 68–75. https://www.ncbi.nlm.nih.gov/pubmed/10877498.https://www.ncbi.nlm.nih.gov/pubmed/10877498

Watts D.H., Spino C. Comparison of gynecologic history and laboratory results in HIV-positive women with CD4+ lymphocyte counts between 200 and 500 cells/μl and below 100 cells/μl // J. AIDS. 1999. No. 20 (5). Р. 455–462. DOI: 10.1097/00042560-199904150-00007..
DOI: 10.1097/00042560-199904150-00007

Fraile P.A. Patient with testosterone deficit syndrome and HIV infection // Arch. Esp. Urol. 2013. No. 66 (7) Р. 696–702.

Mazer N.A. Testosterone deficiency in women: etiologies, diagnosis, and emerging treatments // Int. J. Fertil. 2002. No. 47 (2). Р. 77–86. https://www.ncbi.nlm.nih.gov/pubmed/11991434https://www.ncbi.nlm.nih.gov/pubmed/11991434

Choi H.H., Gray P.B. Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss // J. Clin. Endocrinol. Metab. 2005. No. 90 (3). Р. 1531–1541. DOI: 10.1210/jc.2004–1677..
DOI: 10.1210/jc.2004–1677

Greenblatt R., Ameli N. Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women // J. Infect. Dis. 2000. No. 181. Р. 181–190. DOI: 10.1086/315207..
DOI: 10.1086/315207

Clark R.A., Mulligan K. Frequency of Anovulation and Early Menopause among Women Enrolled in Selected Adult AIDS Clinical Trials Group Studies // Journal of Infectious Diseases. 2001. No. 184. Р. 1325–1327. https://doi.org/10.1086/323999.
DOI: 10.1086/323999

Musaret J., Amneris E. L. Prevalence of Human Papillomavirus Genotypes and Related Abnormalities of Cervical Cytological Results among HIV-1-Infected Women in Rochester. New York // JID. 2006. No. 194. Р. 428–434. https://doi.org/10.1086/505876..
DOI: 10.1086/505876

Firnhaber C., Pettifor A. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa // Cancer Causes Control. 2010. No. 21 (3). Р. 433–443. DOI: 10.1007/s10552-009-9475-z..
DOI: 10.1007/s10552-009-9475-z

Sadhana M. Gupta, Jayanti Mania-Pramanik. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis // J. Biomed Sci. 2019. No. 26. Р. 28. Published online. 2019. Apr. 23. DOI: 10.1186/s12929-019-0520-2..
DOI: 10.1186/s12929-019-0520-2

Leshchenko O., Belyaeva E., Yershova O., Atalyan A., Timofeeva E. The frequency of human papilloma virus in women of reproductive age with HIV infection // Journal of Lower Genital Tract Disease. 2017. No. 21. Р. 39–40.

Soncini E., Zoncada A. Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy // Acta Biomed. 2007. No. 78 (1). Р. 36–40. https://pdfs.semanticscholar.org/056f/7eaafbbd12f495f4adff64bc6eeef1a7a543.pdf.https://pdfs.semanticscholar.org/056f/7eaafbbd12f495f4adff64bc6eeef1a7a543.pdf

Calvert С., Ronsmans С. HIV and the Risk of Direct Obstetric Complications: A Systematic Review and Meta-Analysis // PLoS. One. 2013. No 8 (10). e74848. Published online 2013 Oct 4. DOI: 10.1371/journal.pone.0074848..
DOI: 10.1371/journal.pone.0074848

Pitsos M., Skurnick J. Association of pathologic diagnoses with clinical findings in chronic endometritis // J. Reprod. Med. 2009. No 54 (6). Р. 373–377. https://www.ncbi.nlm.nih.gov/pubmed/19639927.https://www.ncbi.nlm.nih.gov/pubmed/19639927

Mugo N.R., Kiehlbauch J.A. Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis. Obstet. Gynecol. 2006. No. 107 (4). Р. 807–812. DOI: 10.1097/01.AOG.0000207597.70524.e8..
DOI: 10.1097/01.AOG.0000207597.70524.e8

Sebitloane M.H. HIV and gynaecological infections // Best Pract. Res. Clin. Obstet. Gynaecol. 2005. No. 19 (2). Р. 231–241.

Oliveira P.M., Mascarenhas R.E., Ferrer S.R. Vaginal infections in human immunodeficiency virus-infected women // Rev. Bras. Ginecol. Obstet. 2008. No. 30 (3). Р. 121–126. https://www.researchgate.net/publication/23789436_Vaginal_infections_in_human_immunodeficiency_virusinfected_women.https://www.researchgate.net/publication/23789436_Vaginal_infections_in_human_immunodeficiency_virusinfected_women

Watts D.H., Springer G., Minkoff H. Occurrence of vaginal infections among HIV-Infected and high-risk HIV-uninfected women: longitudinal findings of the Women’s Interagency HIV Study // J. AIDS. 2006. No. 43. Р. 161–168. DOI: 10.1097/01.qai.0000242448.90026.13..
DOI: 10.1097/01.qai.0000242448.90026.13

Kibiriqe D., Ssekitoleko R. Endocrine and metabolic abnormalities among HIV-infected patients: a current review // Int. J. STD AIDS. 2013. No. 24. Р. 603–611. DOI: 10.1177/0956462413479895..
DOI: 10.1177/0956462413479895

Zapanti E., Terzidis K., Chrouso G. Dysfuntion of the hypothalamic pituitary adrenal axis in HIV infection and disease // Hormones. 2008. No. 7 (3). Р. 205–216. DOI: 10.14310/horm.2002.1200..
DOI: 10.14310/horm.2002.1200

Бартлетт Д., Галлант Д. Клинические аспекты ВИЧ-инфекции. Балтимор, Мэриленд: Издательская бизнес-руппа Дж. Хопкинса, 2006. 455 с.

Leshchenko O., Genich E. Susceptible hormones in women with HIV‐infection and displeasure // BJOG: An International Journal of Obstetrics & Gynaecology. 2019. No. 126. Р. 217–224. DOI:10.1111/1471-0528.20_15703..
DOI: 10.1111/1471-0528.20_15703

Leshchenko O., Marianian A., Timofeeva E., Atalyan A., Balochova T. HIV infection in men and women of reproductive age // Alcoholism: Clinical and Experimental Research. 2017. No. 41 (6). 150A.

Dillon J.S. Dehydroepiandrosterone, dehydroepiandrosterone sulfate andrelated steroids: their role in inflammatory, allergic and immunological disorders // Curr. Drug Targets Inflamm Allergy. 2005. No. 4. Р. 377–385.

Nassoro D.D., Mkhoi M.L., Sabi I., Meremo A.J., Lawala P.S., Mwakyula I.H. Adrenal Insufficiency: A Forgotten Diagnosis in HIV/AIDS Patients in Developing Countries // Int. J. Endocrinol. 2019; 2019. 2342857. Published online 2019 Jun. 23. DOI: 10.1155/2019/2342857..
DOI: 10.1155/2019/2342857

Shashidhar P.K., Shashikala G.V. Low dose adrenocorticotropic hormone test and adrenal insufficiency in critically ill acquired immunodeficiency syndrome patients // Indian J. Endocrinol. Metab. 2012. No. 16. Р. 389–394. DOI: 10.4103/2230–8210.95680..
DOI: 10.4103/2230–8210.95680

Леви Д.Э. ВИЧ и патогенез СПИДа. М.: Научный Мир, 2010. 736 с.

Barlow-Mosha L., Eckard A.R., McComsey G.A., Musoke P.M. Metabolic complications and treatment of perinatally HIV-infected children and adolescents // J. Int. AIDS Soc. 2013. No. 16 (1). Р. 18600. Published online 2013 Jun 18. DOI: 10.7448/IAS.16.1.18600..
DOI: 10.7448/IAS.16.1.18600

Brown T.T. The effects of HIV-1 infection on endocrine organs // Best Pract. Res. Clin. Endocrinol. Metab. 2011. No. 25. Р. 414. DOI: 10.1016/j.beem.2011.04.005..
DOI: 10.1016/j.beem.2011.04.005

Sanjay K., Hamby S. Human immunodeficiency virus and the endocrine system // Indian J. Endocrinol. Metab. 2011. No. 15 (4). Р. 231–233. DOI: 10.4103/2230–8210.85566..
DOI: 10.4103/2230–8210.85566

Yalamanchi S., Dobs A., Greenblatt R.M. Gonadal function and reproductive health in women with human immunodeficiency virus infection // Endocrinol. Metab. Clin. North Am. 2014. No. 43 (3). Р. 731–741. DOI: 10.1016/j.ecl.2014.05.002..
DOI: 10.1016/j.ecl.2014.05.002

Varthakavi P.K. Thyroid Dysfunction in HIV-AIDS // JAPI. 2009. No. 57. Р. 503–504.

Sinha U., Sengupta N. Human immunodeficiency virus endocrinopathy // Indian J. Endocrinol. Metab. 2011; 15 (4). Р. 251–260. DOI: 10.4103/2230-8210.85574..
DOI: 10.4103/2230-8210.85574

Zaid D., Greenman Y. Human Immunodeficiency Virus Infection and the Endocrine System // Endocrinol. Metab. (Seoul). 2019. Jun; No 34 (2). Р. 95–105. Published online 2019 May 20. DOI: 10.3803/EnM.2019.34.2.95..
DOI: 10.3803/EnM.2019.34.2.95

Ohl J., Partisani M. Alterations of ovarian reserve tests in Human Immunodeficiency Virus (HIV)-infected women // Gynécologie Obstétrique & Fertilité. 2010. Р. 313–317. DOI: 10.1016/j.gyobfe.2009.07.019..
DOI: 10.1016/j.gyobfe.2009.07.019

Willems N., Lemoine C., Liesnard C. Is ovarian function impaired in HIV patients? A clinical pilot study in Burkina Faso // Rev Med Brux. 2013. No. 34 (5). Р. 397–404. https://www.ncbi.nlm.nih.gov/pubmed/24303653.https://www.ncbi.nlm.nih.gov/pubmed/24303653

Scherzer R., Bacchetti P. Impact of CD4+ lymphocytes and HIV infection on Anti-Müllerian Hormone levels in a large cohort of HIV-infected and HIV-uninfected women // Am. J. Reprod. Immunol. 2015. No. 73 (3). Р. 273–284. DOI: 10.1111/aji.12332..
DOI: 10.1111/aji.12332

Язык текста: Русский

ISSN: 2077-9828